Application segmentation dissects the Microneedle Skincare Patches market according to the therapeutic endpoint addressed by the product. Anti‑aging patches, which deliver peptides and antioxidants to stimulate collagen synthesis, dominate the market, accounting for roughly 35 % of total revenue due to strong consumer demand and premium pricing. Hyperpigmentation patches, formulated with niacinamide or tranexamic acid, represent about 25 % of sales, reflecting their niche but growing adoption in regions with high sun exposure. Acne patches, leveraging salicylic acid or benzoyl peroxide, contribute an estimated 20 % of the market, driven by the prevalence of adult acne and the convenience of at‑home treatment. Hair‑growth patches, incorporating minoxidil or plant‑based actives, hold a 10 % share, indicating a modest but expanding segment as male‑ and female‑pattern baldness treatments diversify. The residual 10 % falls under Other applications such as scar remodeling and wound healing, where limited clinical data constrain broader market penetration. This Microneedle Skincare Patches segmentation framework quantifies the relative weight of each application in shaping overall market size.